Understanding nicotine and tobacco addiction /

Saved in:
Bibliographic Details
Meeting name:Symposium on Understanding Nicotine and Tobacco Addiction (2005 : Novartis Foundation)
Imprint:Chichester, UK ; Hoboken, NJ : John Wiley & Sons, 2006.
Description:viii, 275 p. : ill. ; 23 cm.
Language:English
Series:Novartis Foundation symposium ; 275
Subject:
Format: E-Resource Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/6011485
Hidden Bibliographic Details
Other authors / contributors:Bock, Gregory.
Goode, Jamie.
ISBN:0470016574
Notes:Symposium held at the Novartis Foundation, London, 17-19 May 2005.
Includes bibliographical references and indexes.
Table of Contents:
  • Symposium on Understanding nicotine and tobacco addiction, held at the Novartis Foundation, London, 17-19 May 2005
  • Editors: Gregory Bock (Organizer) and Jamie Goode
  • This symposium is based on a proposal made by Robert West and Gino van Heeke
  • Chair's introduction
  • The hazards of smoking and the benefits of stopping
  • Discussion
  • Animal models for nicotine dependence
  • Discussion
  • Defining and assessing nicotine dependence in humans
  • Discussion
  • General discussion I.
  • Nicotinic acetylcholine receptor functions in the CNS investigated with a novel method of stereotaxic gene re-expression in knockout mice
  • Discussion
  • Nicotine-mediated activation of signal transduction pathways
  • Discussion
  • Complementary roles for the accumbal shell and core in nicotine dependence
  • Discussion
  • The dopamine D[subscript 3] system: new opportunities for dopamine-based reward
  • Discussion
  • Pathways and systems involved in nicotine dependence
  • Discussion
  • Localizing tobacco dependence pathways with functional brain imaging
  • Discussion
  • Pharmacogenetic approach to nicotine dependence treatment
  • Discussion
  • Pharmacogenomics and smoking cessation
  • Discussion
  • General discussion II. Power in studies
  • Receptor desensitizadon
  • What limits the efficacy of current nicotine replacement therapies?
  • Discussion
  • Exploring behavioural mechanisms of nicotine replacement therapy for smoking cessation
  • Discussion
  • Modifying the metabolism of nicotine as a therapeutic strategy
  • Discussion
  • Challenges in discovery and development of pharmacotherapies for tobacco addiction
  • Discussion
  • Final discussion: Nicotine comorbidity
  • Animal models
  • Index of contributors
  • Subject index